Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies

Thromb Haemost. 2001 Oct;86(4):1070-6. doi: 10.1186/ar251.

Abstract

We investigated whether beta2-glycoprotein I (beta2GPI), the key antigen in the antiphospholipid syndrome, is susceptible to oxidative modifications by the hydroxyl radical (*OH) that may influence its lipid-binding and antigenic properties. The effects on human and bovine beta2GPI of *OH free radicals generated by gamma-radiolysis of water with 137Cs were studied. Radiolytic *OH caused a dose-dependent loss of tryptophan, production of dityrosine and carbonyl groups. dimerization and/or extensive aggregation of beta2GPI. It ensued a reduction in affinity binding to cardiolipin liposomes and loss of beta2GPI-dependent autoantibody binding to immobilized cardiolipin. Patient anti-beta2GPI antibodies (n = 20) segregated into two groups based on the effect in the beta2GPI-ELISA of beta2GPI pretreatment with *OH: enhancement (group A, n = 10) or suppression (group B, n = 10) of IgG binding. The avidities of group A antibodies for fluid-phase beta2GPI were low but increased in a dose-dependent manner upon beta2GPI irradiation, in relation to protein crosslinking. Distinguishing features of group B antibodies included higher avidities for fluid-phase beta2GPI that was no longer recognized after *OH treatment, and negative anticardiolipin tests suggesting epitope location near the phospholipid binding site. The *OH scavengers thiourea and mannitol efficiently protected against all above changes. Therefore, oxidative modifications of beta2GPI via *OH attack of susceptible amino acids alter phospholipid binding, and modulate recognition by autoantibodies depending on their epitope specificities. These findings may be of clinical relevance for the generation and/or reactivity of anti-beta2GPI antibodies.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Antiphospholipid / immunology
  • Antibody Affinity
  • Antibody Specificity
  • Antigen-Antibody Reactions*
  • Antiphospholipid Syndrome / etiology
  • Antiphospholipid Syndrome / immunology
  • Autoantibodies / immunology*
  • Autoimmune Diseases / immunology
  • Cardiolipins / immunology
  • Cardiolipins / metabolism
  • Cattle
  • Dimerization
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes / immunology
  • Free Radical Scavengers / pharmacology
  • Gamma Rays
  • Glycoproteins / chemistry
  • Glycoproteins / immunology
  • Glycoproteins / metabolism*
  • Humans
  • Hydroxyl Radical / pharmacology*
  • Immunoglobulin G / immunology
  • Immunoglobulin G / metabolism
  • Liposomes
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / immunology
  • Macromolecular Substances
  • Mannitol / pharmacology
  • Oxidation-Reduction
  • Phospholipids / immunology*
  • Phospholipids / metabolism
  • Structure-Activity Relationship
  • Thiourea / pharmacology
  • Thrombophilia / immunology
  • Tryptophan / chemistry
  • Water
  • beta 2-Glycoprotein I

Substances

  • Antibodies, Antiphospholipid
  • Autoantibodies
  • Cardiolipins
  • Epitopes
  • Free Radical Scavengers
  • Glycoproteins
  • Immunoglobulin G
  • Liposomes
  • Macromolecular Substances
  • Phospholipids
  • beta 2-Glycoprotein I
  • Water
  • Hydroxyl Radical
  • Mannitol
  • Tryptophan
  • Thiourea